BRAF V600 Mutation Detection by Immunohistochemistry Shows Tumor Homogeneity between Primary and Metastatic Sites

被引：0
|
作者：
Boursault, L.
Haddad, V.
Jouary, T.
Vergier, B.
Verdon, S.
de Mascarel, A.
Merlio, J. P.
机构：
[1] CHU, Bordeaux, France
[2] Univ Bordeaux, Bordeaux, France
来源：
MODERN PATHOLOGY | 2013年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
455
引用
收藏
页码：111A / 111A
页数：1
相关论文
共 50 条
  • [31] Amelanotic melanoma presenting with plasmacytoid morphology and BRAF V600 mutation
    Kocovski, Linda
    Bane, Anita
    Tang, Shangguo
    Salama, Samih
    Alowami, Salem
    RARE TUMORS, 2015, 7 (02) : 89 - 91
  • [32] High BRAF V600 Mutation Level Associated with Worse Outcome in Metastatic Melanoma Patients Receiving BRAF and MEK Inhibitors
    Fizazi, Ariane
    Serrand, Chris
    Evrard, Alexandre
    Bergeret, Blanche
    Stoebner, Pierre-Emmanuel
    Marque, Myriam
    ACTA DERMATO-VENEREOLOGICA, 2024, 104
  • [33] Intrapatient homogeneity of BRAF V600 status in melanoma with the exception of sentinel lymph node
    Nardin, C.
    Puzenat, E.
    Doussot, A.
    Pretet, J. L.
    Algros, M. P.
    Deveza, E.
    Adotevi, O.
    Aubin, F.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB171 - AB171
  • [34] EFFECTIVENESS OF BRAF INHIBITORS IN PATIENTS WITH BRAF V600 MUTATION POSITIVE GLIOMA: A SYSTEMATIC REVIEW
    Yao, Ian
    Dawson, Sarah
    Higgins, Julian
    McGuinness, Luke
    McAleenan, Alexandra
    Kurian, Kathreena M.
    NEURO-ONCOLOGY, 2019, 21 : 14 - 14
  • [35] Detection of BRAF V600K Mutations in Melanoma: A Comparison of Cobas 4800 BRAF V600 Mutation Test and Laboratory Developed Pyrosequencing Assay
    Wenceslao, S. M.
    Gale, J.
    Vasef, M. A.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2012, 14 (06): : 700 - 701
  • [36] Detection of BRAF V600 Mutations in Metastatic Melanoma Comparison of the Cobas 4800 and Sanger Sequencing Assays
    Qu, Kevin
    Pan, Qiulu
    Zhang, Xi
    Rodriguez, Luis
    Zhang, Ke
    Li, Hairong
    Ho, Albert
    Sanders, Heather
    Sferruzza, Anthony
    Cheng, Shih-Min
    Nguyen, Diedre
    Jones, Dan
    Waldman, Frederic
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2013, 15 (06): : 790 - 795
  • [37] BRAF V600 and non-V600 mutations across distinct tumor types.
    Xie, Qichao
    Huan, Jiaojiao
    Zhao, Jun
    Chen, Yu
    Gao, Jie
    Liang, Naixin
    Zeng, Yu
    Liu, Lianke
    Xu, Chunwei
    Chen, Chen
    Guan, Yan-Fang
    Yang, Ling
    Xia, Xuefeng
    Yi, Xin
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [38] Dabrafenib plus Trametinib: a Review in Advanced Melanoma with a BRAF V600 Mutation
    Dhillon, Sohita
    TARGETED ONCOLOGY, 2016, 11 (03) : 417 - 428
  • [39] Detection of BRAF V600 Mutations in Melanoma: Evaluation of Concordance between the Cobas® 4800 BRAF V600 Mutation Test and the Methods Used in French National Cancer Institute (INCa) Platforms in a Real-Life Setting
    Mourah, Samia
    Denis, Marc G.
    Narducci, Fabienne Escande
    Solassol, Jerome
    Merlin, Jean-Louis
    Sabourin, Jean-Christophe
    Scoazec, Jean-Yves
    Ouafik, L'Houcine
    Emile, Jean-Francois
    Heller, Remy
    Souvignet, Claude
    Bergougnoux, Loic
    Merlio, Jean-Philippe
    PLOS ONE, 2015, 10 (03):
  • [40] Advances in Treatment for Patients Unresectable or Metastatic BRAF V600 Mutated Melanoma
    Ying, A. C. H.
    HONG KONG JOURNAL OF RADIOLOGY, 2013, 16 (04): : S34 - S38
12345